Andrew Brackmann

Stock Analyst

(n/a)
# 4,463
Out of 4,648 analysts
5
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Andrew Brackmann

Tempus AI
Jul 9, 2024
Initiates: Outperform
Price Target: n/a
Current: $49.50
Upside: -
QuidelOrtho
Feb 14, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $39.09
Upside: -
Sight Sciences
Sep 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.66
Upside: -
MDxHealth
Mar 24, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.05
Upside: -